Company: REVB
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0000950170-25-007303
Chunk: 1

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 5.07
Chunk 1
---
 to the conversion limitation which is the subject of such proposal. Since they are interested stockholders with respect to such proposal, they have agreed to vote the shares of common stock in the same proportion that non-interested stockholders vote their shares of common stock. As an example, if 50.5% of the shares of common stock are voted FOR Proposal 3, 50.5% of the votes cast by the Warrant Holders will be cast as votes FOR Proposal 3.

The following proposals, each as described further in the Proxy Statement, were voted upon by the stockholders:

Proposal 1 - Reverse Stock Split

Stockholders approved the board of directors to effect a Reverse Stock Split of the outstanding shares of our common stock within one (1) year of January 17, 2024, at a specific ratio within a range of one-for-2 to a maximum of a one-for-50 split, with the specific ratio to be fixed within this range by the board of directors in its sole discretion without further stockholder approval, based on the votes listed below:

        For      Against      Abstain  
 ───────────────────────────────────────
  3,955,277      162,665       21,665  

There were no broker non-votes regarding this proposal.

Proposal 2 - Change of Domicile

The proposal to change the Company's domicile from Delaware to Nevada, notwithstanding 97% of stockholders present voted in favor of the proposal, did not receive the required number of affirmative votes from the outstanding shares to pass at this time, based on the votes listed below:

        For      Against      Abstain  
 ───────────────────────────────────────
  2,956,575       73,597       20,134  

There were 1,089,301 broker non-votes regarding this proposal.

Proposal 3 - Approval of the Reservation and Issuance of Shares of Our Common Stock

Stockholders approved the reservation and issuance of shares of our common stock pursuant to the Warrants, dated December 3, 2024, entered into between us and certain purchasers in connection with a warrant inducement letter dated the same date, to the extent that issuances under the Warrants may exceed 20% of the Company’s total outstanding shares, which could trigger the Exchange Cap, based on the votes listed below:

        For      Against      Abstain  
 ───────────────────────────────────────
  2,370,106